Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.115, No.8, p.483-486, 2014 |
||
Title: In vitro effect of moxifloxacin and rifampicin on biofilm formation by clinical MRSA isolates | ||
Author: I. Ozturk, A. N. Yurtman, B. Erac, S. Gul-Yurtsever, S. Ermertcan, M. Hosgor-Limoncu | ||
Abstract: Objective: In this study, it was aimed to investigate in vitro activity of moxifloxacin and rifampicin on biofilm formation by clinical MRSA isolates. Background: Methicillin resistant Staphylococcus aureus (MRSA) strains could be the causative agent in chronical and medical device associated infections by biofilm formation. Methods: Moxifloxacin and rifampicin MIC values of 98 MRSA clinical isolates were determined by microdilution method. Biofilm formation of all isolates was determined in 96-well microplates by using spectrophotometric method. Effects of MIC and sub-inhibitory concentrations (1/2 and 1/4 MIC) of antibiotics on biofilm formation were examined in 46 strong biofilm producer strains. Results: Biofilm production decreased in 37 and 44 isolates at all studied concentrations of moxifloxacin and rifampicin, respectively. Biofilm production increased in six isolates with moxifloxacin and in two isolates with rifampicin. Coclusion: Biofilm inhibitory effect of rifampicin was found to be stronger than moxifloxacin in the examined strains. The studied antimicrobials also induced biofilm formation in some strains. Results of this study may help to evaluate the effects of these antibiotics on biofilm formation of clinical MRSA strains and to control the antibiotic resistance in clinical settings (Tab. 2, Ref. 25). |
||
Keywords: biofilm, methicillin resistant Staphylococcus aureus, moxifloxacin, rifampicin. | ||
Year: 2014, Volume: 115, Issue: 8 | Page From: 483, Page To: 486 | |
doi:10.4149/BLL_2014_093 |
||
|
download file |
|